Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
作者信息
Pysyk Christopher L
机构信息
Department of Anesthesiology and Pain Medicine, Faculty of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
出版信息
JAMA Intern Med. 2020 Feb 1;180(2):332. doi: 10.1001/jamainternmed.2019.5861.
Abstract
摘要
相似文献
1
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.接受直接口服抗凝剂治疗的心房颤动患者的硬膜外导管使用及其他问题
JAMA Intern Med. 2020 Feb 1;180(2):332. doi: 10.1001/jamainternmed.2019.5861.
2
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.接受直接口服抗凝剂治疗的心房颤动患者的硬膜外导管使用及其他问题
JAMA Intern Med. 2020 Feb 1;180(2):332-333. doi: 10.1001/jamainternmed.2019.5864.
3
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant-Reply.接受直接口服抗凝剂治疗的心房颤动患者使用硬膜外导管及其他相关问题——回复
JAMA Intern Med. 2020 Feb 1;180(2):333-334. doi: 10.1001/jamainternmed.2019.5851.
4
Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动缺血性卒中患者口服抗凝剂的选择
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2627-2631. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.036. Epub 2018 Jun 30.
5
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.种族/民族与心房颤动患者口服抗凝药物使用的相关性：来自更好地了解心房颤动治疗的结果登记 II 研究的结果。
JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.
6
Safety and Efficacy of Uninterrupted Direct Oral Anticoagulant Administration in Elderly Patients Undergoing Catheter Ablation of Atrial Fibrillation.
JACC Clin Electrophysiol. 2018 May;4(5):601-603. doi: 10.1016/j.jacep.2018.04.004.
7
Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF).房颤导管消融围手术期口服抗凝剂报告：日本房颤导管消融注册研究（J-CARAF）
J Arrhythm. 2017 Jun;33(3):172-176. doi: 10.1016/j.joa.2016.10.002. Epub 2016 Oct 27.
8
Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.老年患者行导管消融术治疗心房颤动时不停用直接口服抗凝药与华法林的对比：与年轻患者的比较。
JACC Clin Electrophysiol. 2018 May;4(5):592-600. doi: 10.1016/j.jacep.2018.02.013. Epub 2018 May 2.
9
In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.美国房颤抗凝时代华法林和直接口服抗凝剂致心肌梗死患者院内出血结局：来自全国心血管数据注册急性冠脉治疗和干预结局网络注册的报告。
J Am Heart Assoc. 2019 Apr 16;8(8):e011606. doi: 10.1161/JAHA.118.011606.
10
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.心房颤动卒中后抗凝治疗的三个月风险效益概况：SAMURAI-非瓣膜性心房颤动（NVAF）研究
Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.
Zotero 插件